Cointime

DarioHealth

company

About

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

Highlights

Stock Symbol
nasdaq:DRIO
Total Funding Amount
$240M
Funding Rounds
19
Investors
12
Acquisition
3
Employee Profiles
15

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$5.10M
Industries
Health Care,Health Diagnostics,Medical Device,Software,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
101 - 250
Operating Status
Active
Stock Symbol
nasdaq:DRIO
Legal Name
DarioHealth Corp.
Also Known As
Labstyle Innovations

DarioHealth is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
19
$240M
DarioHealth has raised a total of $240M in funding over 2 rounds. Their latest funding was raised on Jun 9, 2022 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 9, 2022 Post-IPO Debt $50M 1 OrbiMed — Detail
Jan 27, 2021 Post-IPO Equity $70M 6 — — Detail
Jul 21, 2020 Post-IPO Equity $28.60M 5 — — Detail
Oct 22, 2019 Post-IPO Equity $21.30M 1 — — Detail
Sep 16, 2018 Post-IPO Equity $10.34M — — — Detail
Show More

Investors

Number of Lead Investors
Number of Investors
2
12
DarioHealth is funded by 12 investors. OrbiMed and OurCrowd are the most recent investors.
Investor Name Lead Investor Funding Round
OrbiMed Yes Post-IPO Debt
OurCrowd Yes Post-IPO Equity
Phoenix Insurance Company — Post-IPO Equity
Driehaus Capital Management — Post-IPO Equity
Farallon Capital Management — Post-IPO Equity
Nantahala Capital Management — Post-IPO Equity
Perceptive Advisors — Post-IPO Equity
Pura Vida Investments — Post-IPO Equity
Psagot Investment House — Post-IPO Equity
Soleus Capital — Post-IPO Equity
Show More

Employee Profiles

Number of Employee Profiles
15
DarioHealth has 15 current employee profiles, including Employee Oded Cohen
Oded Cohen
Employee
Yoav Shaked
Board member
Eric Milledge
Employee
Adam Stern
Executive
Omar Manejwala
Executive
Show More

Acquisition

DarioHealth has acquired 3 organizations. Their most recent acquisition was Upright Technologies on Jan 27, 2021. They acquired Upright Technologies for $31M.

Date Company Name
Industry Acquisition Type Price
Jan 27, 2021 Upright Technologies
Health Care acquisition $ 31M Detail
May 18, 2021 wayForward
Health Care acquisition $ 25M Detail
Jan 20, 2022 PhysiMax Technologies
Artificial Intelligence acquisition $ 1.02M Detail
Cointime
Содержание
компания